HEALTH AND SAFETY

» Drug, Devices, and Supplements

» Physician Accountability

» Consumer Product Safety

» Worker Safety

» Health Care Delivery

» Auto and Truck Safety

» Global Access to Medicines

» Infant Formula Marketing

 

Product Recalls

February 13, 2014 – March 12, 2014


Health Letter, April 2014

Class I

A number of dietary supplements manufactured by Mira Health Products Ltd. have been recalled. For details, visit http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=Expand+Index&w=03122014&lang=eng#drugs

Class II

A number of products manufactured by Natures Pharmacy & Compounding Center have been recalled. For details, visit http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=Expand+Index&w=03122014&lang=eng#drugs

A number of lansoprazole delayed release capsules manufactured by Dr. Reddy's Laboratories Inc. have been recalled. For details, visit http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1146-2014&w=03122014&lang=eng

A number of products manufactured by Teva Pharmaceuticals USA have been recalled. For details, visit http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=Expand+Index&w=03122014&lang=eng#drugs

Alprazolam Extended-Release Tablets, USP, 3 mg, 60-count tablets per bottle. http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1091-2014&w=03122014&lang=eng

Clonazepam Tablets, USP 2 mg 100 tablets. http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1087-2014&w=03052014&lang=eng.

Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle. http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1082-2014&w=02192014&lang=eng

Levothyroxine Sodium Tablets, USP, 200 mcg, 100-count bottle. http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1084-2014&w=02192014&lang=eng

Metformin HCl Extended-Release Tablets, USP, 500 mg, 500 count bottles. http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1089-2014&w=03052014&lang=eng

Oxcarbazepine Tablets, 300 mg, 100 tablet bottles. http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1081-2014&w=02192014&lang=eng

CONSUMER PRODUCTS


For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.